Journal
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
Volume -, Issue 415, Pages S132-S137Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.blo.0000092981.12414.7b
Keywords
-
Categories
Ask authors/readers for more resources
Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available